

parkinson's disease | Research | Treatment | 10 pages | source: Journal of Parkinson's disease | Added May 08, 2025
Gocovri treatment decreases dyskinesia and off times in patients with Parkinson's disease
This study investigated the effectiveness of Gocovri (amantadine) in the treatment of dyskinesia (DYS) in patients with Parkinson's disease (PD). Researchers suggested that this treatment improves DYS symptoms.

diabetes mellitus | Research | 10 pages | source: Diabetes Research and Clinical Practice | Added May 08, 2025
Alcohol and drug use in young adults with type 1 diabetes
This article examined the prevalence of alcohol and drug use in young adults with type 1 diabetes (T1D). They also investigated the ways these substances can affect the health of young adults with T1D.

coronary artery disease | Research | 9 pages | source: Atherosclerosis | Added May 07, 2025
Will an intensive statin treatment change composition of plaque?
This paper studied the effect of an early intensive statin treatment in patients who have had a heart attack.


erectile dysfunction | Research | Treatment | 10 pages | source: The journal of sexual medicine | Added May 07, 2025
Intralesional therapy and Peyronie's disease
This study looked at different types of intralesional therapy in the treatment of Peyronie's disease (PD). It concluded that different therapies could affect different aspects of PD.


parkinson's disease | Research | Treatment | 10 pages | source: Journal of Parkinson's disease | Added May 06, 2025
Opicapone is a safe option to treat patients with Parkinson's disease
This study investigated the safety profile of opicapone (Ongentys) in the treatment of Parkinson's disease. Researchers suggested that this drug was safe and well-tolerated in these patients.

diabetes mellitus | Medivizor | source: Medivizor | Added May 06, 2025
Diabetes and Nanotechnology



erectile dysfunction | Research | Treatment | 10 pages | source: BJU international | Added May 05, 2025
Predicting success for Collagenase clostridium histolyticum treatment in Peyronie's disease
This study looked at the effectiveness of injection of Collagenase Clostridium histolyticum (Xiaflex) (CCh) to treat Peyronie's disease. This study concluded CCh was effective after injection, in the treatment of patients with more severe Peyronie's disease.

coronary artery disease | Research | 10 pages | source: Journal of the American College of Cardiology | Added May 05, 2025
Can lowering blood pressure be a bad thing?
This study examined whether there was a link between low diastolic blood pressure (DBP) and the frequency of angina in patients with coronary artery disease (CAD; heart disease caused by a low blood supply to the heart because of hardened and narrowed blood vessels). The authors concluded that low DBP is associated with an increased risk of angina in these patients.


overactive bladder | Research | Treatment | 10 pages | source: European Urology | Added May 04, 2025
The safety and effectiveness of Mirabegron and Sulifenacin for Overactive Bladder
This study looked at the safety and effectiveness of combination Mirabegron (Myrbetriq) and Solifenacin (Vesicare) treatment in Overactive Bladder (OAB) patients. This study concluded that after 1 year, the combination treatment was safe and more effective than each drug given alone.

diabetes mellitus | Research | 10 pages | source: Diabetes Research and Clinical Practice | Added May 04, 2025
Gestational diabetes increases the risk of metabolic syndrome after pregnancy
The aim of this study was to investigate the risk of metabolic syndrome after pregnancy in women that had gestational diabetes (GD). The main finding of the study was women who had GD had a higher risk of metabolic syndrome after pregnancy.